Prognostic impact of cardiohepatic syndrome in patients with ST-segment elevation myocardial infarction

Mustafa A Sungur1, Aylin Sungur2, Ali Karagöz3

  • 1Department of Cardiology, Dr. Siyami Ersek Thoracic & Cardiovascular Surgery Education Research Hospital, Selimiye Mh. Tıbbiye Cd. No: 25 Üsküdar, İstanbul, Turkey.

Biomarkers in Medicine
|April 12, 2023
PubMed

Insights

Cardiohepatic syndrome (CHS) significantly increases mortality risk in ST-segment elevation myocardial infarction (STEMI) patients. Early CHS evaluation is crucial for risk stratification and improving patient outcomes.

Area of Science:

  • Cardiology
  • Hepatology
  • Internal Medicine

Background:

  • Cardiohepatic syndrome (CHS) describes the complex interplay between cardiac and liver function.
  • Understanding CHS is vital, particularly in acute cardiovascular events.

Purpose of the Study:

  • To assess the impact of CHS on mortality in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention.
  • To identify CHS as a prognostic factor in STEMI.

Main Methods:

  • A cohort of 1541 STEMI patients who underwent primary percutaneous coronary intervention was analyzed.
  • CHS was diagnosed by elevated levels of at least two of three cholestatic liver enzymes: total bilirubin, alkaline phosphatase, and gamma-glutamyl transferase.

Main Results:

  • CHS was identified in 144 (9.34%) of the studied STEMI patients.
  • Multivariate analysis confirmed CHS as an independent predictor of both in-hospital (OR: 2.48) and long-term mortality (HR: 2.4).

Conclusions:

  • The presence of CHS is associated with a poorer prognosis in STEMI patients.
  • CHS should be incorporated into the risk stratification protocols for STEMI patients.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
18
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
15
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
41
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
14
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
29
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
20